| # | Drug | Count |
|---|---|---|
| 0 | ESOMEPRAZOLE MAGNESIUM | 14 |
| 1 | PREDNISOLONE | 11 |
| 2 | PREDNISOLONE ORAL | 11 |
| 3 | PREDNISOLONE ORAL SOLUTION | 11 |
| 4 | ASPIRIN | 9 |
| 5 | TACROLIMUS | 9 |
| 6 | ASPIRIN 325 MG | 8 |
| 7 | ASPIRIN 81 MG | 8 |
| 8 | FUROSEMIDE | 8 |
| 9 | OMEPRAZOLE MAGNESIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DELGOCITINIB | 1 | 0.0037 |
| 1 | CICLOPIROX OLAMINE | 1 | 0.0021 |
| 2 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| 3 | CEFACLOR | 2 | 0.0013 |
| 4 | TEDIZOLID PHOSPHATE | 1 | 0.0012 |
| 5 | ETELCALCETIDE | 3 | 0.0010 |
| 6 | EFINACONAZOLE | 2 | 0.0010 |
| 7 | 2%MENTHOL | 1 | 0.0010 |
| 8 | COUGH SUPPRESSANT | 1 | 0.0010 |
| 9 | RALTEGRAVIR | 5 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Antiseptic [EPC] | 2 | 0.0005 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 5 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 6 | Allylamine Antifungal [EPC] | 2 | 0.0003 |
| 7 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 9 | Progestin Antagonist [EPC] | 1 | 0.0002 |